244219-96-3 Usage
Chemical compound
A chemical compound with the molecular formula C9H9N3.
Derivative
A derivative of isoquinoline.
Pharmaceutical industry
Has potential use in the pharmaceutical industry.
Antineoplastic agent
Potential use as an antineoplastic agent.
Topoisomerase inhibitor
Potential use as a topoisomerase inhibitor.
Anti-cancer properties
Has been studied for its potential anti-cancer properties.
Inhibiting cancer cell growth
Has shown promise in inhibiting the growth of certain cancer cells.
Other medical conditions
Investigated for its potential role in treating other medical conditions such as inflammation and neurodegenerative diseases.
Further research
More research is needed to fully understand the potential uses and mechanisms of action of 1,7-Isoquinolinediamine(9CI).
Check Digit Verification of cas no
The CAS Registry Mumber 244219-96-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,4,4,2,1 and 9 respectively; the second part has 2 digits, 9 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 244219-96:
(8*2)+(7*4)+(6*4)+(5*2)+(4*1)+(3*9)+(2*9)+(1*6)=133
133 % 10 = 3
So 244219-96-3 is a valid CAS Registry Number.
244219-96-3Relevant articles and documents
Fragment based search for small molecule inhibitors of HIV-1 Tat-TAR
Zeiger, Mirco,Stark, Sebastian,Kalden, Elisabeth,Ackermann, Bettina,Ferner, Jan,Scheffer, Ute,Shoja-Bazargani, Fatemeh,Erdel, Veysel,Schwalbe, Harald,G?bel, Michael W.
supporting information, p. 5576 - 5580 (2015/01/08)
Basic molecular building blocks such as benzene rings, amidines, guanidines, and amino groups have been combined in a systematic way to generate ligand candidates for HIV-1 TAR RNA. Ranking of the resulting compounds was achieved in a fluorimetric Tat-TAR
Synthesis and antimalarial activity of 7-benzylamino-1-isoquinolinamines
Gutteridge, Clare E.,Hoffman, Marshall M.,Bhattacharjee, Apurba K.,Gerena, Lucia
, p. 633 - 637 (2008/09/17)
(Chemical Equation Presented) Computer modelling suggests that 7-benzylamino-1-isoquinolinamines should mediate antimalarial effects by a mechanism distinct from that employed by existing antimalarial drugs. A series of these compounds was prepared in sev
